The Portugal Biotech Investor Day is organized by the European Innovation Council (EIC) and CUF that is part of the José de Mello Group. The event will comprise of health-related innovators working on Med-Tech, E-Health and Bio-Tech and will be held on 29-30 November in Lisbon.
Companies that will be selected to receive funding will be selected by an investor jury from top European VCs and CVCs in the healthcare sector.
Health-related companies will have the opportunity to pitch their business to top EU later-stage investors like Apex Ventures, Armilar Venture Partners, BioGeneration Ventures, Bionova Capital, Coparion, Clinical Research Ventures, Earlybird, Firstminute Capital, Mustard Seed Maze, Octopus Ventures, Pathena Investments, Redalpine, Seroba Life Sciences, Shilling VC and Sofinnova Partners.
The EIC Business Acceleration Services connect investors and companies in Europe. For the upcoming Investor Day, EIC is collaborating with CUF that is the market-leader in the health-care sector in Portugal with over 11,000 employees. As innovation is at the core of its activities, CUF works closely with universities, scientific institutes and start-ups.
Another upcoming event in the Health Sector is organized by the European Innovation Council (EIC) and the European Medicines Agency (EMA) on 31 January 2023. The online event will introduce support services provided to researchers and SMEs in the pharmaceutical and med-tech sectors. Companies that are innovative in the health-tech sector at different stages of development as well as those that would like to apply to the EMA services such as PRIME or Scientific Advice are invited to participate. EMA support services include gene and cell therapies and the Innovation Task Force (ITF).
The Health and Bio-Tech sector in Portugal is attracting massive investments, such as Amgen the global pioneer in Biotechnology that just announced an investment of Euros 100 million in Portugal, and further developments in the field are to be expected.
Source: https://www.portugalbusinessesnews.com/post/portugal-biotech